Notes on Gram Positive Rods and Tetanus
Gram Positive Rods Overview
- Definition: Bacteria that retain the crystal violet stain used in the Gram staining procedure.
Endospore Forming Gram Positive Rods (GPR)
Characteristics:
- Can survive extreme conditions such as:
- Lack of food
- Temperature extremes
- Lack of moisture
- Metabolically inactive when in spore form, making them resistant to destruction.
Examples:
- Clostridium spp. (anaerobic)
- Bacillus spp. (aerobic)
Non-Endospore Forming Gram Positive Rods
Characteristics:
- Lack the ability to form endospores.
Examples:
- Corynebacterium
- Listeria
- Gardnerella (variable Gram staining)
- Lactobacillus
- Propionibacterium acnes
- Actinomycetes (weakly acid-fast)
- Mycobacterium (acid-fast)
Clostridium Species
- General Characteristics:
- Anaerobic GPR that produce endospores and are associated with destructive toxins.
Specific Clostridium Species:
Clostridium tetani
- Morphology: Round, terminal endospores resembling tennis rackets or lollipops.
- Disease: Tetanus (caused by neurotoxin tetanospasmin)
- Mechanism: Blocks muscle relaxation, leading to rigid contraction ("lockjaw") and muscle spasms.
Clostridium botulinum
- Morphology: Oval, sub-terminal endospores.
Clostridium perfringens
- Morphology: Oval, sub-terminal endospores, usually causing double zone hemolysis.
Clostridioides difficile
- Morphology: Oval, sub-terminal endospores, has a characteristic odor similar to horse manure.
Tetanus (Clostridium tetani)
Pathology:
- First Symptom: Stiffness of the jaw (lockjaw), progressing to severe muscle spasms.
- Affected individuals may experience:
- Rigid muscles in back and legs
- Potentially fatal muscle spasms leading to respiratory failure.
Mechanism of Tetanus Toxin:
- Toxin binds to inhibitory interneurons, reducing the release of neurotransmitters (glycine and GABA).
- Inhibition leads to constant muscle contraction.
Transmission and Infection Risks
- Common Sources of Infection:
- Soil, particularly around animal feces.
- Entry routes:
- Deep tissue injections (e.g., through puncture wounds)
- IV drug use with non-sterile equipment.
- At-Risk Populations:
- 70% of cases in the U.S. are in individuals over age 50 whose vaccinations are not up to date.
Tetanus Prevention and Treatment
Vaccination:
- DTP Vaccine: Inactivated toxin that stimulates antibody production for immunity against tetanus.
- Booster Shots: Required every 10 years (Tdap) to maintain immunity; many in the U.S. are unvaccinated.
Post-exposure Treatment:
- Unvaccinated individuals may receive tetanus immune globulin (TIG) for immediate protection.
- Antibiotics (e.g., metronidazole) can eliminate the bacteria.
Note: Awareness of symptoms is crucial for diagnosis, as cultures are only positive in 30% of cases.